PARKINSON'S DISEASE NEWS
27th April 2010 - News release
THE FURTHER WITHDRAWAL OF NEUPRO
22nd April 2010 - New research
DYES ARE STRONGLY ASSOCIATED WITH PARKINSON'S DISEASE
International journal of Neuroscience  120 (5)
: 361-367 (Hristina VD, Sipetic SB, Maksimovic JM, Marinkovic JM, Dzoljic ED,
Ratkov IS, Kostic VS.)
18th April 2010 - New research
GLYCOPYRROLATE FOR SIALORRHEA IN PARKINSON'S DISEASE
Neurology  74 (15) : 1203-1207 (Arbouw ME,
Movig KL, Koopmann M, Poels PJ, Guchelaar HJ, Egberts TC, Neef C, van Vugt JP)
In a clinical trial the severity of the sialorrhea was scored on a daily basis by the patients or a caregiver with a sialorrhea scoring scale ranging from 1 (no sialorrhea) to 9 (profuse sialorrhea). Around 39% of people taking glycopyrrolate had a clinically relevant improvement of at least 30%, without side effects. The authors concluded that 1 mg 3 times daily is an effective and safe therapy for sialorrhea in Parkinson disease. However, these results also mean that around 60% of people with Parkinson's Disease do not significantly benefit from its use. In order to refer to this article on its own click here.
14th April 2010 - New research
THE EFFECT OF NEUPRO ON PARKINSON'S DISEASE
In April 2008, Neupro was
withdrawn from use in the U.S.A. because specific batches of Neupro had deviated
from their specification. UCB is working with the U.S. FDA so that Neupro can be
available to patients with early-stage Parkinson's Disease as soon as possible.
Neupro is not approved for use in Canada either, but is available in Europe. For
more information go to the
In order to refer to this
article on its own
12th April 2010 - New book
DEEP BRAIN STIMULATION PROGRAMMING : PRINCIPLES AND PRACTICE
Publisher's description : Deep Brain Stimulation (DBS) is a remarkable therapy for an expanding range of neurological disorders, including Parkinson's Disease. Post-operative programming of the DBS systems seems unfamiliar, even mysterious, and is viewed as difficult and time consuming. Even these principles can be relatively easy to grasp. The book helps the reader to obtain an intuitive understanding of the basic principles of electronics, electrophysiology and the relevant regional anatomy through the use of readily understood metaphors and numerous illustrations. The book provides an introduction to where some of the new theories may lead particularly with the growing awareness of the importance of oscillations in the brain's activities. The brain has more in common with electrical devices, such as computers, than it does to a stew of chemicals. Click here for more details. For more books concerning Parkinson's Disease go to Parkinson's Disease Books.
2nd April 2010 - News release
STALEVO IS LINKED TO PROSTATE CANCER
The U.S. Food and Drug Administration (FDA) is evaluating clinical trial data suggesting that patients taking Stalevo, may be at an increased risk for developing prostate cancer. The number of people taking Stalevo with prostate cancer was small, but it was still four times what would otherwise be expected. The FDA's review of Stalevo is ongoing and so no new conclusions or recommendations about the use of this drug have been made. They consequently suggest that "Patients should not stop taking their medication unless directed to do so by their healthcare professional". For more information go to the News release. In order to refer to this article on its own click here.